Harris Associates Portfolio holdings
Harris Associates is a value-focused stock picker that runs the Oakmark family of mutual funds and ETFs. Its founders, including Victor Morgenstern, had earlier worked in the private investment office of Irving Harris, a Chicago entrepreneur, before starting the firm in the 1970s. The firm looks for companies whose shares trade below its own estimate of what the business is worth, and it applies that approach to large, mid-sized and small companies in the United States and abroad, on a long-only basis. Harris is owned by Natixis Investment Managers, a Paris-based asset management group, but it makes its own investment decisions. Its clients range from high net worth individuals and charities to pension plans, insurers and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$673M |
| 3 |
Netflix
NFLX
|
+$600M |
| 4 |
Marsh
MRSH
|
+$382M |
| 5 |
American Express
AXP
|
+$381M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 3 |
Constellation Brands
STZ
|
+$431M |
| 4 |
Targa Resources
TRGP
|
+$426M |
| 5 |
IQVIA
IQV
|
+$421M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.07% |
| 2 | Healthcare | 12.85% |
| 3 | Technology | 12.58% |
| 4 | Industrials | 10.25% |
| 5 | Consumer Discretionary | 9.84% |
Similar funds
Harris Associates's Q3 2026 Portfolio in Review
As of Q3 2026, Harris Associates held 184 positions worth $76.8B, up 1.8% from $75.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Harris Associates's Q3 2026 filing shows 22 new, 36 increased, 88 reduced and 8 closed positions. Its largest new stake was Rocket Companies: 26,577,141 shares worth $306M. The largest sale was Merck, an estimated $1.03B.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Technology.
- Harris Associates's largest Q3 2026 buy was Rocket Companies: 26,577,141 shares worth $306M.
- Harris Associates added most to Meta Platforms (Facebook) in Q3 2026, an estimated $1.51B increase.
- Harris Associates's biggest Q3 2026 reduction was Merck, cutting an estimated $1.03B.
- Harris Associates fully exited Constellation Brands in Q3 2026, selling an estimated $431M.
- Harris Associates's ten largest holdings make up 31% of its $76.8B portfolio in Q3 2026.
- Harris Associates opened 22 new positions and closed 8 in Q3 2026.
- Harris Associates's portfolio value rose 1.8% quarter-over-quarter to $76.8B.
Based on Harris Associates's 13F filing for Q3 2026, filed 16 Nov 2026.